In certain epithelialmalignancies, moreover, resistance to TGF-β1-mediated growth suppression is often coupled withEGFR amplification or dysregulated EGFR signaling, particularly during thelater stages of tumor development [14–19]. The gene discussed is EGFR; the disease is neoplasm.